oxamic acid has been researched along with Chronic Disease in 3 studies
Oxamic Acid: Amino-substituted glyoxylic acid derivative.
oxamic acid : A dicarboxylic acid monoamide resulting from the formal condensation of one of the carboxy groups of oxalic acid with ammonia.
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
| Excerpt | Relevance | Reference |
|---|---|---|
| "The efficacy of lodoxamide tromethamine in the treatment of asthma was studied in a 16-week double-blind, placebo-controlled study of 68 perennial allergic subjects with asthma." | 9.05 | Inhaled lodoxamide tromethamine in the treatment of perennial asthma: a double-blind placebo-controlled study. ( Clement, P; Fairfax, AJ; Holgate, ST; Mann, JS; Sheridan, AQ; Soryal, I, 1985) |
| "The efficacy of lodoxamide tromethamine in the treatment of asthma was studied in a 16-week double-blind, placebo-controlled study of 68 perennial allergic subjects with asthma." | 5.05 | Inhaled lodoxamide tromethamine in the treatment of perennial asthma: a double-blind placebo-controlled study. ( Clement, P; Fairfax, AJ; Holgate, ST; Mann, JS; Sheridan, AQ; Soryal, I, 1985) |
| "Diagnoses were chronic allergic conjunctivitis, vernal conjunctivitis, seasonal and atopic conjunctivitis." | 2.69 | Treatment of common ocular allergic disorders; a comparison of lodoxamide and NAAGA. ( Bloch-Michel, E; Denis, D; Di Giovanni, A; Helleboid, L; Lecorvec, M; Sebastiani, A; Tazartes, M; Verin, P, 1998) |
| "1% was well tolerated and minor adverse effects not requiring stopping the medication were reported in only 4." | 1.48 | Efficacy and safety of 0.1% lodoxamide for the long-term treatment of superior limbic keratoconjunctivitis. ( Gonzalez-Gonzalez, JM; Macias-Rodriguez, Y; Rodriguez-Garcia, A, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rodriguez-Garcia, A | 1 |
| Macias-Rodriguez, Y | 1 |
| Gonzalez-Gonzalez, JM | 1 |
| Denis, D | 1 |
| Bloch-Michel, E | 1 |
| Verin, P | 1 |
| Sebastiani, A | 1 |
| Tazartes, M | 1 |
| Helleboid, L | 1 |
| Di Giovanni, A | 1 |
| Lecorvec, M | 1 |
| Mann, JS | 1 |
| Clement, P | 1 |
| Sheridan, AQ | 1 |
| Soryal, I | 1 |
| Fairfax, AJ | 1 |
| Holgate, ST | 1 |
2 trials available for oxamic acid and Chronic Disease
| Article | Year |
|---|---|
Treatment of common ocular allergic disorders; a comparison of lodoxamide and NAAGA.
Topics: Adolescent; Adult; Aged; Anti-Allergic Agents; Child; Child, Preschool; Chronic Disease; Conjunctivi | 1998 |
Inhaled lodoxamide tromethamine in the treatment of perennial asthma: a double-blind placebo-controlled study.
Topics: Adolescent; Adult; Aerosols; Amino Acids; Asthma; Chronic Disease; Double-Blind Method; Female; Huma | 1985 |
1 other study available for oxamic acid and Chronic Disease
| Article | Year |
|---|---|
Efficacy and safety of 0.1% lodoxamide for the long-term treatment of superior limbic keratoconjunctivitis.
Topics: Administration, Topical; Adult; Aged; Anti-Allergic Agents; Chronic Disease; Conjunctiva; Dose-Respo | 2018 |